{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T05:50:07Z","timestamp":1788587407743,"version":"build-2803163510"},"reference-count":20,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2017,7,3]],"date-time":"2017-07-03T00:00:00Z","timestamp":1499040000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004099","name":"Ligue Contre le Cancer","doi-asserted-by":"publisher","award":["AL-250\/16"],"award-info":[{"award-number":["AL-250\/16"]}],"id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0180346","type":"journal-article","created":{"date-parts":[[2017,7,3]],"date-time":"2017-07-03T13:35:57Z","timestamp":1499088957000},"page":"e0180346","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":44,"title":["PD-L1 expression in pleomorphic, spindle cell and giant cell carcinoma of the lung is related to TTF-1, p40 expression and might indicate a worse prognosis"],"prefix":"10.1371","volume":"12","author":[{"given":"Violaine","family":"Yvorel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Patoir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Casteillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Tissot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Fournel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Laure","family":"Stachowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia","family":"Karpathiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Tiffet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"P\u00e9oc\u2019h","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7582-3923","authenticated-orcid":true,"given":"Fabien","family":"Forest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,7,3]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.humpath.2015.10.006","article-title":"Histomolecular profiling of pleomorphic, spindle cell, and giant cell carcinoma of the lung for targeted therapies","volume":"49","author":"F Forest","year":"2016","journal-title":"Hum Pathol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1056\/NEJMoa1606774","article-title":"Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer","volume":"375","author":"M Reck","year":"2016","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.lungcan.2016.05.013","article-title":"Sarcomatoid lung carcinomas show high levels of programmed death ligand-1 (PD-L1) and strong immune-cell infiltration by TCD3 cells and macrophages","volume":"98","author":"T Vieira","year":"2016","journal-title":"Lung Cancer"},{"key":"ref4","article-title":"WHO classification of tumours of lung, pleura, thymus and heart","author":"WD Travis","year":"2015"},{"issue":"7","key":"ref5","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17071046","article-title":"PD-L1 Immunohistochemical Detection in Tumor Cells and Tumor Microenvironment: Main Considerations on the Use of Tissue Micro Arrays","volume":"17","author":"G Botti","year":"2016","journal-title":"Int J Mol Sci"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ejca.2016.03.012","article-title":"High co-expression of PD-L1 and HIF-1\u03b1 correlates with tumour necrosis in pulmonary pleomorphic carcinoma","volume":"60","author":"Y-L Chang","year":"2016","journal-title":"Eur J Cancer"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1097\/JTO.0b013e318292be18","article-title":"Sarcomatoid Lung Carcinomas Show High Levels of Programmed Death Ligand-1 (PD-L1)","volume":"8","author":"V Velcheti","year":"2013","journal-title":"J Thorac Oncol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1016\/j.ejca.2015.08.013","article-title":"Programmed death-1 ligand 1 and 2 are highly expressed in pleomorphic carcinomas of the lung: Comparison of sarcomatous and carcinomatous areas","volume":"51","author":"S Kim","year":"2015","journal-title":"Eur J Cancer"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.lungcan.2016.07.010","article-title":"Nivolumab-induced organizing pneumonitis in a patient with lung sarcomatoid carcinoma","volume":"99","author":"V Gounant","year":"2016","journal-title":"Lung Cancer"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.jtho.2016.04.007","article-title":"Prognostic Significance of PD-L1 in Patients with Non\u2013Small Cell Lung Cancer: A Large Cohort Study of Surgically Resected Cases","volume":"11","author":"J-M Sun","year":"2016","journal-title":"J Thorac Oncol"},{"key":"ref11","article-title":"PD-L1 Immunohistochemistry Assays for Lung Cancer: Results from Phase 1 of the \u00ab Blueprint PD-L1 IHC Assay Comparison Project \u00bb","author":"FR Hirsch","year":"2016","journal-title":"J Thorac Oncol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/modpathol.2011.173","article-title":"p40 (\u0394Np63) is superior to p63 for the diagnosis of pulmonary squamous cell carcinoma","volume":"25","author":"JA Bishop","year":"2012","journal-title":"Mod Pathol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1080\/17476348.2017.1235975","article-title":"The impact of immunohistochemistry on the classification of lung tumors","volume":"10","author":"G Pelosi","year":"2016","journal-title":"Expert Rev Respir Med"},{"issue":"8","key":"ref14","doi-asserted-by":"crossref","first-page":"e0136023","DOI":"10.1371\/journal.pone.0136023","article-title":"PD-1 and PD-L1 Expression in NSCLC Indicate a Favorable Prognosis in Defined Subgroups","volume":"10","author":"LH Schmidt","year":"2015","journal-title":"PloS One"},{"key":"ref15","article-title":"Programmed cell death-ligand 1 (PD-L1) expression and fibroblast growth factor receptor 1 (FGFR1) amplification in stage III\/IV lung squamous cell carcinoma (SQC)","author":"Q Guo","year":"2016","journal-title":"Thorac Cancer"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.lungcan.2015.01.016","article-title":"Clinicopathological analysis of PD-L1 and PD-L2 expression in pulmonary squamous cell carcinoma: Comparison with tumor-infiltrating T cells and the status of oncogenic drivers","volume":"88","author":"M-Y Kim","year":"2015","journal-title":"Lung Cancer"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/j.jtho.2016.08.134","article-title":"Programmed Cell Death Ligand 1 Expression in Resected Lung Adenocarcinomas: Association with Immune Microenvironment","volume":"11","author":"TG Huynh","year":"2016","journal-title":"J Thorac Oncol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/modpathol.2016.213","article-title":"Heterogeneous expression of PD-L1 in pulmonary squamous cell carcinoma and adenocarcinoma: implications for assessment by small biopsy","volume":"30","author":"TJ Gniadek","year":"2017","journal-title":"Mod Pathol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/annonc\/mdv489","article-title":"Comparative study of the PD-L1 status between surgically resected specimens and matched biopsies of NSCLC patients reveal major discordances: a potential issue for anti-PD-L1 therapeutic strategies","volume":"27","author":"M Ilie","year":"2016","journal-title":"Ann Oncol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/j.jtho.2016.06.004","article-title":"Characterization of 298 Patients with Lung Cancer Harboring MET Exon 14 Skipping Alterations","volume":"11","author":"AB Schrock","year":"2016","journal-title":"J Thorac Oncol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0180346","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T18:42:54Z","timestamp":1540233774000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0180346"}},"subtitle":[],"editor":[{"given":"Aamir","family":"Ahmad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,7,3]]},"references-count":20,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2017,7,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0180346","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,3]]}}}